Zurzuvae differs from traditional antidepressants as it is the first oral treatment approved for postpartum depression (PPD), but it’s not yet approved for major depressive disorder (MDD). It’s only taken for 14 days and it’s a faster-acting antidepressant, with symptom improvement starting as early as the third day.